NZ708812A - Fviii peptides, compositions and uses of same - Google Patents

Fviii peptides, compositions and uses of same

Info

Publication number
NZ708812A
NZ708812A NZ708812A NZ70881213A NZ708812A NZ 708812 A NZ708812 A NZ 708812A NZ 708812 A NZ708812 A NZ 708812A NZ 70881213 A NZ70881213 A NZ 70881213A NZ 708812 A NZ708812 A NZ 708812A
Authority
NZ
New Zealand
Prior art keywords
present
compositions
same
haemophilia
fviii
Prior art date
Application number
NZ708812A
Other languages
English (en)
Inventor
David Wraith
Heather Streeter
Original Assignee
Apitope Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1220328.7A external-priority patent/GB201220328D0/en
Priority claimed from GBGB1316660.8A external-priority patent/GB201316660D0/en
Application filed by Apitope Int Nv filed Critical Apitope Int Nv
Publication of NZ708812A publication Critical patent/NZ708812A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ708812A 2012-11-12 2013-11-11 Fviii peptides, compositions and uses of same NZ708812A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1220328.7A GB201220328D0 (en) 2012-11-12 2012-11-12 Peptides
GBGB1316660.8A GB201316660D0 (en) 2013-09-19 2013-09-19 Peptides
PCT/IB2013/060060 WO2014072958A1 (en) 2012-11-12 2013-11-11 Peptides

Publications (1)

Publication Number Publication Date
NZ708812A true NZ708812A (en) 2019-03-29

Family

ID=49627013

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ708812A NZ708812A (en) 2012-11-12 2013-11-11 Fviii peptides, compositions and uses of same

Country Status (28)

Country Link
US (2) US20150306192A1 (enExample)
EP (1) EP2917232B1 (enExample)
JP (1) JP6247696B2 (enExample)
KR (1) KR102165486B1 (enExample)
CN (1) CN104903347B (enExample)
AU (1) AU2013343024B2 (enExample)
BR (1) BR112015010625B1 (enExample)
CA (1) CA2890835C (enExample)
CY (1) CY1119164T1 (enExample)
DK (1) DK2917232T3 (enExample)
EA (1) EA036483B1 (enExample)
ES (1) ES2626881T3 (enExample)
HR (1) HRP20170794T1 (enExample)
HU (1) HUE033586T2 (enExample)
IL (1) IL238627B (enExample)
IN (1) IN2015DN03814A (enExample)
LT (1) LT2917232T (enExample)
MX (1) MX350777B (enExample)
MY (1) MY176708A (enExample)
NZ (1) NZ708812A (enExample)
PH (1) PH12015501033B1 (enExample)
PL (1) PL2917232T3 (enExample)
PT (1) PT2917232T (enExample)
RS (1) RS56069B1 (enExample)
SG (1) SG11201503657UA (enExample)
SI (1) SI2917232T1 (enExample)
WO (1) WO2014072958A1 (enExample)
ZA (1) ZA201503127B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018206358B2 (en) 2017-01-04 2021-05-27 Worg Pharmaceuticals (Zhejiang) Co., Ltd. S-Arrestin peptides and therapeutic uses thereof
EP3715374A1 (en) 2019-03-23 2020-09-30 Ablevia biotech GmbH Compound for the sequestration of undesirable antibodies in a patient
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
GB201909774D0 (en) 2019-07-08 2019-08-21 Apitope Tech Bristol Limited Method
WO2022063887A1 (en) 2020-09-23 2022-03-31 Ablevia Biotech Gmbh Compound for increasing the efficacy of factor viii replacement therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030062321A (ko) 2000-08-21 2003-07-23 아피토프 테크놀러지 (브리스톨) 리미티드 펩티드 선별 방법
US20040096456A1 (en) * 2000-12-01 2004-05-20 Conti-Fine Bianca M Method to treat hemophilia
FR2842812A1 (fr) * 2002-07-26 2004-01-30 Pf Medicament Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse
JP2006188507A (ja) * 2004-12-10 2006-07-20 Tokyo Univ Of Agriculture & Technology 蛋白質の溶解度向上方法
EP1945797B1 (en) * 2005-10-28 2012-05-30 Boehringer Ingelheim International GmbH Hepatitis c virus ns2/3 activity assay
GB0723712D0 (en) * 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
CA2780763A1 (en) * 2009-11-13 2011-05-19 Puget Sound Blood Center Factor viii b cell epitope variants having reduced immunogenicity
PL3260132T3 (pl) * 2010-10-27 2022-08-08 Takeda Pharmaceutical Company Limited Peptydy fviii do wywoływania tolerancji immunologicznej oraz immunodiagnostyki

Also Published As

Publication number Publication date
KR20150084852A (ko) 2015-07-22
CN104903347A (zh) 2015-09-09
PH12015501033A1 (en) 2015-07-27
HUE033586T2 (hu) 2017-12-28
ZA201503127B (en) 2016-10-26
SI2917232T1 (sl) 2017-07-31
PH12015501033B1 (en) 2015-07-27
MX350777B (es) 2017-09-15
EA201590927A1 (ru) 2015-10-30
ES2626881T3 (es) 2017-07-26
DK2917232T3 (en) 2017-06-12
EP2917232B1 (en) 2017-03-01
BR112015010625A2 (pt) 2017-08-22
WO2014072958A8 (en) 2016-10-13
US20210346476A1 (en) 2021-11-11
IL238627A0 (en) 2015-06-30
IN2015DN03814A (enExample) 2015-10-02
JP6247696B2 (ja) 2017-12-13
PL2917232T3 (pl) 2017-09-29
IL238627B (en) 2018-12-31
WO2014072958A1 (en) 2014-05-15
US20150306192A1 (en) 2015-10-29
HK1209138A1 (en) 2016-03-24
CY1119164T1 (el) 2018-02-14
BR112015010625B1 (pt) 2023-03-07
MX2015005973A (es) 2015-09-16
MY176708A (en) 2020-08-19
AU2013343024A1 (en) 2015-05-21
CA2890835C (en) 2021-11-23
SG11201503657UA (en) 2015-06-29
RS56069B1 (sr) 2017-10-31
EA036483B1 (ru) 2020-11-16
KR102165486B1 (ko) 2020-10-15
JP2016501182A (ja) 2016-01-18
AU2013343024B2 (en) 2017-06-01
EP2917232A1 (en) 2015-09-16
LT2917232T (lt) 2017-06-26
CN104903347B (zh) 2020-02-21
CA2890835A1 (en) 2014-05-15
HRP20170794T1 (hr) 2017-08-11
PT2917232T (pt) 2017-06-09

Similar Documents

Publication Publication Date Title
MX2023001403A (es) Neoantigenos y metodos de su uso.
CY1121560T1 (el) Ανοσογονικη συνθεση
EP4296673A3 (en) Peptides and methods for the detection of lyme disease antibodies
WO2018187356A3 (en) Protein antigens and uses thereof
PH12014501410A1 (en) Compositions and methods for antibodies targeting factor p
UA112416C2 (uk) Антитіло до fap і способи його застосування
CL2012002095A1 (es) Polipéptido de unión biparatópico que comprende un primer dominio variable individual de inmunoglobulina (ig) que se une específicamente a un primer epítopo del péptido ß-amiloide (ßa) y un segundo dominio variable de ig que se une específicamente a un segundo epítopo del ßa, donde dichos epítopos del ßa no son idénticos; ácido nucleico que lo codifica; vector; célula hospedera; composición farmacéutica; método de preparación; y su uso en el tratamiento y/o prevención de depósitos del ßa
UA118167C2 (uk) Пептид та його застосування
EA201490644A1 (ru) Терапевтические пептиды
EP4356927A3 (en) Antibody based reagents that specifically recognize toxic oligomeric forms of tau
IN2014DN03451A (enExample)
WO2014043509A3 (en) Single domain antibody with c-terminal modification
PH12015501033A1 (en) Peptides
MY168207A (en) Fviii-derived peptides
ECSP10010327A (es) Péptidos del fviii y su uso para hemofílicos tolerantes
GB201118201D0 (en) Novel peptides
UA113413C2 (uk) Пептид mphosph1 та вакцина, що його містить
EP3974443A3 (en) Peptides derived from melanoma-associated antigen b2 (mageb2)
MX2015012905A (es) Formulaciones de factor viii recombinantes.
MX344586B (es) Peptidos tomm34 y vacunas que los incluyen.
WO2014152831A3 (en) Targeting peptides and uses thereof
MX2013004417A (es) Peptidos wdhd1 y vacunas que los incluyen.
WO2013104918A3 (en) Binding molecule
WO2014201400A3 (en) Anti-factor viii antibodies or uses thereof
HK1200724A1 (en) Chlamydia antigen compositions and uses thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 NOV 2020 BY RENEWALS TEAM

Effective date: 20191104

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 NOV 2021 BY ENVOY

Effective date: 20210506

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 NOV 2022 BY ENVOY

Effective date: 20211111

ASS Change of ownership

Owner name: WORG PHARMACEUTICALS (HANGZHOU) CO., LTD., CN

Effective date: 20220303

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 NOV 2023 BY RENEWALS TEAM

Effective date: 20221203

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 NOV 2024 BY DENNEMEYER + CO.

Effective date: 20231031

LAPS Patent lapsed